The Ministry of Health, Labor and Welfare (MHLW) on December 12 presented a draft outline of the FY2026 drug pricing…
HOME > BUSINESS
BUSINESS
- Bayer Yakuhin Now Marketing Authorization Holder for Claritin
November 16, 2015
- Taiho Files for Japan Approval of Allergy Drug Bilastine
November 16, 2015
- Senju, Gene Techno to Form Capital Tie-Up for Biosimilar Development in Ophthalmology
November 16, 2015
- NHI Prices of Plavix Generics “Actually 43% Rather than 50% Price of Original Product”: Sawai Pharmaceutical President
November 16, 2015
- Japanese Makers Earn Overseas in 1st Half, Japan Sales Up Only Slightly: Tally
November 13, 2015
- OrphanPacific Aims to Achieve Black Ink in 2017
November 13, 2015
- Astellas to Transfer Global Dermatology Portfolio to LEO Pharma
November 12, 2015
- Sovaldi Best-Selling Drug in July-September after May Launch: IMS
November 11, 2015
- Astellas to Acquire US Biotech Ocata Therapeutics for US$379 Million
November 11, 2015
- Top 4 Wholesalers See 7% Sales Rise on Hep C Drugs, but Paltry 0.82% in Operating Margin
November 11, 2015
- Chugai, Kowa Expand Licensing Deal for Deberza
November 11, 2015
- Ethical Dug Sales Climb 7.8% in September: Crecon Report
November 11, 2015
- Fujifilm’s AML Drug Candidate to Enter PI in US
November 11, 2015
- Shionogi, GSK to Independently Develop Jointly Researched Antibiotics
November 10, 2015
- Jardiance Jumps into Top 20 Ranking on Physicians’ Recollection: Anterio
November 10, 2015
- AZ’s Lung Cancer Treatment Gets Priority Review Status in Japan
November 9, 2015
- Half-Year Revenues of 4 Japanese Majors Beat Projections on Buoyant Global Products
November 6, 2015
- Ono Now Has Oncology Sales Force of 180, Eyes Lung Cancer Indication for Opdivo
November 6, 2015
- Nichi-Iko Eyes Generic Production Capacity of 21 Billion Tablets by 2021
November 5, 2015
- AbbVie Files Humira for Non-Infectious Uveitis
November 5, 2015
ページ
Let’s ditch the stuffy jargon and talk about AI in HR like real humans.One of the biggest myths floating around is that AI is coming to steal our jobs. Newsflash: that’s not happening. Sure, AI can handle the boring stuff…
Novartis’ Pluvicto (lutetium vipivotide tetraxetan (177Lu)) won reimbursement listing in Japan in November as a radioligand therapy (RLT) for PSMA-positive…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…